PUMA BIOTECHNOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.095 USD | -7.14% |
|
-14.86% | -5.43% |
| May. 17 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
| May. 02 | Transcript : Puma Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Other Biotechnology & Medical Research | -7.14% | -14.86% | -5.43% | +44.19% | -75.32% | 198M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- PBYI Stock
- Charts Puma Biotechnology, Inc.
- Comparison Chart